Boehringer Ingelheim Director of Business Development Salaries in Newark, NJ
The average Boehringer Ingelheim Director of Business Development in Newark, NJ earns an estimated $180,897 annually, which includes an estimated base salary of $140,272 with a $40,625 bonus. Boehringer Ingelheim's Director of Business Development compensation is $14,631 more than the US average for a Director of Business Development. Director of Business Development salaries at Boehringer Ingelheim in Newark, NJ can range from $120,000 - $270,000.
In Newark, NJ, The Business Development Department at Boehringer Ingelheim earns $824 more on average than the HR Department.
Last updated 2 months ago.
- $140,272
- avg. base
- $40,625
- avg. bonus
Director of Business Development Salaries at Boehringer Ingelheim
In Newark, NJ, Directors of Business Development earn $1,085 more than Directors of Business Development.
Compensation at Boehringer Ingelheim by Department
In Newark, NJ, The Business Development Department averages $824 more than the HR Department, and $3,137 less than the IT Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Boehringer Ingelheim reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Boehringer Ingelheim reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Boehringer Ingelheim Rate Their Compensation
The majority of Directors of Business Development at Boehringer Ingelheim believe they're compensated fairly. The vast majority (73%) of Directors of Business Development at Boehringer Ingelheim are satisfied with their benefits. See more compensation ratings at Boehringer Ingelheim
